Clinical Trials Logo

Filter by:
NCT ID: NCT06420050 Not yet recruiting - Heavy Drinking Clinical Trials

Testing a Novel Instagram Intervention for Heavy Alcohol Use

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

This project aims to test the efficacy of an Instagram-based intervention for reducing heavy alcohol use. More specifically, the investigators will use a randomized controlled design to analyze differences in alcohol use and alcohol-related outcomes (e.g., alcohol-related consequences, etc.) as well as differences in the use of protective behavioral strategies and mindfulness practices. Participants (80 Prolific users who report binge drinking) will be randomly assigned to 1 of 3 conditions: intervention or control. Those who are randomized to the intervention condition will be invited to follow study Instagram pages, and those who are randomized to the control condition will be invited to complete the assessments only. The investigators hypothesize that there will be greater reductions in alcohol use, frequency, and consequences and greater frequency of use of mindfulness exercises and protective behavioral strategies among those in the intervention condition as compared to those in the control condition.

NCT ID: NCT06419985 Not yet recruiting - Clinical trials for Complex Regional Pain Syndromes

Ketamine HCl Prolonged Release Oral Tablets for CRPS

Start date: June 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetic profile of Ketamine HCl Prolonged Release (PR) tablets in participants with pain due to complex regional pain syndrome (CRPS). Additionally, this trial will explore the feasibility of the trial design through dosing compliance, clinical instruments, and efficacy signals.

NCT ID: NCT06419959 Not yet recruiting - Clinical trials for Cardiovascular Diseases

NightWare and Cardiovascular Health in Veterans With PTSD

Start date: October 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about the effectiveness of a prescription wrist-wearable device called NightWare (NW) on improving sleep in Veterans with nightmares related to posttraumatic stress disorder (PTSD). The investigators also want to learn whether it improves cardiovascular health among this population.

NCT ID: NCT06419920 Not yet recruiting - Amputation Clinical Trials

Prosthetic Performance Enhancement Trial

PROSPER
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to determine the feasibility of an uneven terrain walking program for lower limb prosthesis users. The training is designed to induce step-to-step variability during walking within a safe environment, with the aim of improving walking skill and confidence.

NCT ID: NCT06419803 Not yet recruiting - Pregnancy Related Clinical Trials

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

START2
Start date: May 27, 2024
Phase: N/A
Study type: Interventional

The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a Strict and permissive threshold. The Strict study arm target range will be 65-120 mg/dL, with time in range goal of 70%. The permissive study arm target range will be 65-140 mg/dL, with target time in range goal of 70%.

NCT ID: NCT06419777 Not yet recruiting - Pregnancy Related Clinical Trials

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

START 1
Start date: May 31, 2024
Phase: N/A
Study type: Interventional

The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a strict and permissive threshold. The strict threshold is defined as two abnormal values or more over a one-week period (two fasting values elevated, two of the same post prandial values elevated, or 1 fasting and 1 post prandial value elevated), whereas the permissive threshold is defined as 50% of values elevated over 1 week (50% of overall fasting values, 50% of postprandial values, or 50% of overall values).

NCT ID: NCT06419634 Not yet recruiting - Clinical trials for Acute Myeloid Leukemia

Study of BMS-986497 (ORM-6151) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Start date: May 30, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, drug levels, drug efficacy and determine the recommended dose of BMS-986497 in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

NCT ID: NCT06419439 Not yet recruiting - Depression Clinical Trials

Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

Start date: December 1, 2025
Phase: Phase 2
Study type: Interventional

This is a pilot study to evaluate the feasibility, acceptability, and safety of ketamine infusions followed by a brief behavioral intervention in Veterans with chronic low back pain and depression.

NCT ID: NCT06419218 Not yet recruiting - Nutrition, Healthy Clinical Trials

Increasing School Meal Participation

Start date: September 2024
Phase: N/A
Study type: Interventional

This study aims to determine whether an online marketing campaign increases children's school meal participation. Parents whose children do not currently eat school meals frequently will be exposed to messages designed to encourage their children's increased participation in school meals.

NCT ID: NCT06419075 Not yet recruiting - Clinical trials for Pelvic Organ Prolapse

Tranexamic Acid in Vaginal Reconstructive Surgery

TEXAS
Start date: July 1, 2024
Phase: Phase 4
Study type: Interventional

Tranexamic acid (TXA) has been demonstrated to reduce blood loss in trauma, orthopedic, cardiac, and plastic surgeries in numerous well-designed and adequately powered studies. As a result of this evidence for benefit, TXA is routinely used to reduce blood loss during these surgeries. There are no studies regarding the use of TXA in urogynecology. The investigators seek to explore the effect and safety of local infiltration of TXA in vaginal reconstructive surgery.